Literature DB >> 26801673

Biological characteristics of a novel giant cell tumor cell line derived from spine.

Zhenhua Zhou1,2,3, Yan Li4, Leqin Xu1,5, Xudong Wang1, Su Chen1, Cheng Yang1, Jianru Xiao6.   

Abstract

Giant cell tumor of bone(GCTB) is a special bone tumor for it consists of various cell types, and its biological characteristics is different from common benign or malignant neoplasm. In the present study, we report the biological features of a primary Asian GCTB cell line named GCTB28. We analyzed extensive properties of the GCTB28 cells including morphological observations, growth, cell cycle, karyotype, proliferation, proteins expression, surface biomarker verification, and tumorigenicity in nude mice. We found that the stromal cells of GCTB were endowed with self-renewal capacity and played dominant roles in GCTB development. Moreover, we confirmed that GCTB cells can be CD33(-)CD14(-) phenotype which was not in accord with previous study. This study provides an in vitro model system to investigate pathogenic mechanisms and molecular characteristics of GCTB and also provides a useful tool for researching the therapeutic targeting of GCTB.

Entities:  

Keywords:  Biomarker; Giant cell tumor of bone (GCTB); Mononuclear stromal cells; Multinuclear giant cells; Novel cell line of GCTB

Mesh:

Substances:

Year:  2016        PMID: 26801673     DOI: 10.1007/s13277-016-4867-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  44 in total

1.  Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.

Authors:  L Huang; J Xu; D J Wood; M H Zheng
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.

Authors:  Yong Liu; Honggen Liu; Xuegang Luo; Jingyu Deng; Yuan Pan; Han Liang
Journal:  Tumour Biol       Date:  2015-01-28

3.  Giant-cell tumor of bone. An analysis of two hundred and eighteen cases.

Authors:  R R Goldenberg; C J Campbell; M Bonfiglio
Journal:  J Bone Joint Surg Am       Date:  1970-06       Impact factor: 5.284

4.  Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma.

Authors:  K Emoto; Y Yamada; H Sawada; H Fujimoto; M Ueno; T Takayama; K Kamada; A Naito; S Hirao; Y Nakajima
Journal:  Cancer       Date:  2001-09-15       Impact factor: 6.860

5.  Monocyte-macrophage lineage of giant cell tumor of bone. Establishment of a multinucleated cell line.

Authors:  T S Huang; A D Green; C W Beattie; T K Das Gupta
Journal:  Cancer       Date:  1993-03-01       Impact factor: 6.860

6.  Establishment of a cell line from a human giant cell tumor of bone.

Authors:  M Kito; H Moriya; A Mikata; K Harigaya; T Takenouchi; N Takada; S Tatezaki; T Umeda
Journal:  Clin Orthop Relat Res       Date:  1993-09       Impact factor: 4.176

7.  Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients.

Authors:  Mariana Ferreira Leal; Danielle Queiroz Calcagno; Janete Chung; Vanessa Morais de Freitas; Samia Demachki; Paulo Pimentel Assumpção; Roger Chammas; Rommel Rodríguez Burbano; Marília Cardoso Smith
Journal:  Clin Exp Med       Date:  2014-07-18       Impact factor: 3.984

Review 8.  The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target.

Authors:  Mahesh C Sharma; Meena Sharma
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

9.  Primary malignancies of bone and cartilage in Karachi.

Authors:  Yasmin Bhurgri; Ahmed Usman; Hadi Bhurgri; Naveen Faridi; Imtiaz Bashir; Asif Bhurgri; Sheema H Hasan; Mohammad Khurshid; S M H Zaidi
Journal:  Asian Pac J Cancer Prev       Date:  2009

10.  Testes-specific protease 50 promotes cell invasion and metastasis by increasing NF-kappaB-dependent matrix metalloproteinase-9 expression.

Authors:  Z B Song; J-S Ni; P Wu; Y L Bao; T Liu; M Li; C Fan; W J Zhang; L G Sun; Y X Huang; Y X Li
Journal:  Cell Death Dis       Date:  2015-03-26       Impact factor: 8.469

View more
  2 in total

1.  ALCAM+ stromal cells: role in giant cell tumor of bone progression.

Authors:  Zhenhua Zhou; Yan Li; Xudong Wang; Jingjing Hu; Muyu Kuang; Zhiwei Wang; Song Li; Weidong Xu; Jianru Xiao
Journal:  Cell Death Dis       Date:  2018-02-20       Impact factor: 8.469

Review 2.  Osteoclasts in Tumor Biology: Metastasis and Epithelial-Mesenchymal-Myeloid Transition.

Authors:  Kemal Behzatoglu
Journal:  Pathol Oncol Res       Date:  2021-04-30       Impact factor: 3.201

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.